SIGN UP
LOG IN
A
01672
Ascletis Pharma
8.61
-0.49-5.38%Closed16:08 06/27 HKT
OPEN/PREV CLOSE9.110/9.100
TODAY RANGE8.560-9.300
VOL4.79M
MARKET CAP8.35B
52 WEEK RANGE0.760-11.200
AVG VOL (3M)6.41M
% TURNOVER0.49%
TURNOVER41.78M
P/E (TTM)-25.534
% RANGE8.13%
EPS(TTM)-0.337
P/E(FORWARD)-24.398
P/B3.908
BVPS2.203
DIVIDEND--
P/S6,150.000
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.30B
SHARES OUTSTANDING969.43M
NEXT EARNINGS--
FREE FLOAT963.65M
LOT SIZE1000
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·06/17 01:03
We're Hopeful That Ascletis Pharma (HKG:1672) Will Use Its Cash Wisely
Reuters·06/04 09:27
BUZZ-Sagimet soars as oral acne drug aces late-stage trial in China
Reuters·05/22 10:00
ASCLETIS PHARMA INC - PHASE I TRIAL DOSING EXPECTED TO START IN Q3 2025
Reuters·05/20 10:00
ASCLETIS PHARMA INC - TOPLINE DATA FROM STUDY EXPECTED IN Q4 2025
Simply Wall St·05/12 23:35
Ascletis Pharma Inc. (HKG:1672) CEO Jinzi Jason Wu, the company's largest shareholder sees 7.9% reduction in holdings value
Reuters·03/12 06:31
BUZZ-China's Ascletis hits 6-year peak on good results for weight loss drug
Simply Wall St·02/19 22:26
Here's Why We're Not Too Worried About Ascletis Pharma's (HKG:1672) Cash Burn Situation
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.